Linezolid Zentiva

Linezolid, the active ingredient in Linezolid Zentiva, is an oxazolidinone presented as an oral dosage form for oral use. It treats infections caused by resistant Gram‑positive bacteria, including MRSA and VRE, and is used in community‑acquired pneumonia and skin infections. GNH USA supplies Linezolid Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid Zentiva is an oxazolidinone antibiotic indicated for several serious bacterial infections. - Methicillin‑resistant Staphylococcus aureus (MRSA) infections: provides effective bacterial clearance where beta‑lactams fail. - Vancomycin‑resistant Enterococcus (VRE) infections: offers an alternative treatment option for resistant enterococcal disease. - Community‑acquired pneumonia: targets susceptible Streptococcus pneumoniae and atypical pathogens. - Skin and soft tissue infections: resolves infections caused by susceptible Gram‑positive organisms, including complicated cellulitis.

Linezolid Zentiva may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count, increasing bleeding risk. - Anemia: reduced red blood cell production leading to fatigue. - Peripheral neuropathy: tingling or numbness in extremities. - Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents. - Lactic acidosis: accumulation of lactate causing metabolic disturbance. - Optic neuropathy: visual disturbances due to nerve involvement.

Before initiating therapy, consider the following precautions. - Blood count monitoring: regularly assess platelet and hemoglobin levels. - Serotonergic drug avoidance: do not co‑administer with SSRIs, SNRIs, or MAO inhibitors. - Renal and hepatic function: evaluate organ status, especially in prolonged courses. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Hypersensitivity: discontinue if allergic reactions such as rash or anaphylaxis occur. - Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture.

Linezolid can interact with several medication classes.

Major Interactions (Avoid): - Serotonergic agents (SSRIs, SNRIs, MAO inhibitors): risk of serotonin syndrome. - Monoamine oxidase inhibitors: may cause hypertensive crisis. - Rifampin: reduces linezolid plasma concentrations, compromising efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Anticonvulsants (e.g., carbamazepine): may increase risk of myelosuppression. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive effect on platelet inhibition.